| Literature DB >> 30767348 |
Yong Cheng1,2, Chunli Sun2, Rui Liu1, Juliang Yang1, Jun Dai2, Tianyou Zhai2, Xiaoding Lou1, Fan Xia1,2.
Abstract
Gene therapy has immense potential as a therapeutic approach to serious diseases. However, efficient delivery and real-time tracking of gene therapeutic agents have not been solved well for successful gene-based therapeutics. Herein we present a versatile gene-delivery strategy for efficient and visualized delivery of therapeutic genes into the targeted nucleus. We developed an integrin-targeted, cell-permeable, and nucleocytoplasmic trafficking peptide-conjugated AIEgen named TD NCP for the efficient and sequential targeted delivery of an antisense single-stranded DNA oligonucleotide (ASO) and tracking of the delivery process into the nucleus. As compared with TD NCP/siRNA-NPs (siRNA functions mainly in the cytoplasm), TD NCP/ASO-NPs (ASO functions mainly in the nucleus) exhibited a better interference effect, which further indicates that TD NCP is a nucleus-targeting vector. Moreover, TD NCP/ASO-NPs showed a favorable tumor-suppressive effect in vivo.Entities:
Keywords: AIE luminogens; antisense oligonucleotides; gene delivery; multifunctional peptides; nucleus targeting
Year: 2019 PMID: 30767348 DOI: 10.1002/anie.201901527
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336